Direct acoustic cochlear implant

From WikiMD's Food, Medicine & Wellness Encyclopedia

Direct Acoustic Cochlear Implant (DACI) is a type of hearing aid technology designed for individuals with severe to profound sensorineural hearing loss in the high frequencies and normal or near-normal hearing in the low frequencies. Unlike traditional cochlear implants, which bypass the ear's natural acoustic processing to directly stimulate the auditory nerve, DACIs work by directly driving the cochlea's structures with acoustic energy. This approach preserves the natural acoustic hearing in the low frequencies while providing amplified sound in the high frequencies where hearing is impaired.

Overview[edit | edit source]

Direct Acoustic Cochlear Implants are indicated for patients who do not benefit sufficiently from conventional hearing aids but have too much residual hearing to qualify for a standard cochlear implant. The DACI system consists of an external processor that captures sound and an implantable actuator that directly stimulates the cochlea. The external processor resembles that of a conventional hearing aid, capturing sound and converting it into digital signals. These signals are then processed and sent to the implanted actuator, which vibrates the cochlear structures directly, bypassing damaged hair cells that typically impede sound transmission in individuals with sensorineural hearing loss.

Components[edit | edit source]

The DACI system comprises two main components:

  • External Processor: Similar to a behind-the-ear hearing aid, it captures and processes sound.
  • Implantable Actuator: A surgically implanted device that directly vibrates the cochlea's structures.

Surgical Procedure[edit | edit source]

The implantation of a Direct Acoustic Cochlear Implant is a surgical procedure performed under general anesthesia. The surgeon makes an incision behind the ear to access the cochlea. The actuator is then attached to the cochlea, and the external processor is positioned behind the ear. Post-surgery, patients undergo a period of recovery and adjustment to optimize the device settings for their specific hearing needs.

Benefits and Limitations[edit | edit source]

Benefits of DACIs include the preservation of residual low-frequency hearing, improved speech recognition in noise, and enhanced sound quality for high-frequency sounds. However, limitations exist, such as the risk of surgical complications, the potential for residual hearing loss, and the need for regular device maintenance and adjustments.

Candidates[edit | edit source]

Ideal candidates for Direct Acoustic Cochlear Implants are those with severe to profound high-frequency hearing loss, with relatively intact low-frequency hearing. Candidates must have a clear understanding of the benefits and limitations of the device and be committed to the post-operative rehabilitation process.

Conclusion[edit | edit source]

Direct Acoustic Cochlear Implants represent a significant advancement in hearing aid technology, offering an alternative for individuals with specific types of hearing loss. By directly stimulating the cochlea, DACIs provide a unique solution for improving hearing in patients who cannot benefit from traditional hearing aids or cochlear implants.


Resources[edit source]

Latest articles - Direct acoustic cochlear implant

PubMed
Clinical trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Direct acoustic cochlear implant for any updates.



Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD